Theta Research
  • Console
  • Supply Chain
  • Stock ResearchPro
  • Event Outlook
θDecision Desk
  • DBDashboard55
  • POPortfolio
  • CACalendar
  • SCScreening
  • IMImpact
  • RERegime
  • TRTrack Record

Conclusions are published after independent cross-review.

KDPKeurig Dr Pepper Inc.
BuyConviction 2.9/10PW target $32.00+0.8%Rated Apr 12Full research page

Verdict

KDP is a dual-platform North American beverage leader undergoing a transformative M&A cycle: the $18.4B JDE Peet's acquisition (closed April 2026) creates a ~$26B revenue global coffee powerhouse + a standalone US refreshment beverages business, with a planned tax-free spinoff by year-end 2026. The investment case rests on Beverage Co.'s consistent mid-single-digit organic growth (Dr Pepper gained CSD share for 9 consecutive years) and Coffee Co.'s global scale synergies ($200M+ supply chain savings over 3 years), offset by significant leverage (pro forma 4.5x net debt/EBITDA) and execution risk on separation.

ScenarioProb.TargetDriver
Bull25%$40.00Clean tax-free separation by Q4 2026 — Beverage Co. and Global Coffee Co. both achieve target leverage
Base50%$33.00JDE Peet's integration proceeds without major disruption; synergy capture on track
Bear25%$22.00Separation delayed indefinitely due to leverage concerns or market conditions

Change history

  • Apr 12View held

    Phase A deep research completion — first full thesis build for KDP

Watching

  • JDE Peet's acquisition completed — 96.22% of shares acquiredApr 197d ago
  • JDE Peet's remaining shares tender deadlineApr 1385d ago
  • Q1 2026 earnings — first post-acquisition quarter validation (leverage, integration costs, organic growth)Apr 2474d ago
  • JDE Peet's delisting from Euronext AmsterdamApr 3068d ago
  • Q2 2026 earningsJul 24in 17d
  • Deleveraging to target: Bev Co 3.5-4.0x, Coffee Co 3.75-4.25x
Jul 24
in 17d
  • Q3 2026 earningsOct 29in 114d
  • Keurig Alta next-gen brewer launch — re-engagement of 47M installed baseDec 1in 147d
  • Separation operational readiness targetDec 31in 177d
  • Separation operational readiness — IT carve-out, standalone financials, legal entity setupDec 31in 177d
  • Q4 2026 / FY2026 earnings — first full-year combined resultsFeb 24, 2027in 232d
  • Separation delayed beyond mid-2027 or abandoned — conglomerate discount persists indefinitely
  • Pro forma net leverage remains above 4.5x through Q2 2027 — rating agency downgrade risk materializes
  • Keurig US single-serve market share drops below 45% (from 53%) as Nespresso Vertuo accelerates above 20%
  • Dr Pepper CSD share gains reverse for 2+ consecutive quarters — organic growth engine stalls
  • JDE Peet's integration costs exceed $500M or synergy capture falls below $100M over 3 years
  • Arabica coffee C contract sustains above $3/lb through 2027 — Coffee Co. margins compress >400bp
  • Private-label K-Cup pod revenue exceeds Keurig branded pod revenue in Nielsen/IRI data
  • Separation operational readiness confirmed by year-end 2026 with specific spin date announced
  • Q1 2026 earnings show pro forma leverage at or below 4.5x with standalone organic growth 4-6%
  • Beverage Co. standalone financials disclosed showing 25%+ EBIT margins and mid-single-digit organic growth
  • Keurig Alta next-gen brewer beta results show 20%+ higher pod consumption vs legacy brewers
  • Dr Pepper achieves 10th consecutive year of CSD share gains

    • Latest notes

    • Apr 12Deep Research: KDP — Dual-Platform Beverage Leader in Transformative M&A Cycle
    • Apr 12Competitive Deep Dive: KDP — Divergent Moat Trajectories Create Separation Asymmetry
    • Mar 18Lite Research: KDP — S&P 500 coverage

    Exposure

    1-hop
    Suppliers

    None mapped.

    Customers
    • WMTBeverages and single-serve beverage systems

    Options radar

    Concept — illustrative data
    • Jun 30Call$110.00Aug 211,200 ct$540K
    • Jun 30Call$105.00Jul 17800 ct$216K
    • Jun 29Put$95.00Aug 21600 ct$168K
    Unusual volume3.2x 20-day avg call volume
    IV shift30-day IV 41% → 48%

    Positioning skews toward near-term upside